Medicare Enrolled
Dr. Robert Berryman, M.D.
Medical Oncology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Berryman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berryman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berryman
Dr. Robert Berryman is a medical oncology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Berryman performed 104,583 Medicare services across 2,896 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berryman received a total of $162,583 from 49 pharmaceutical and/or device companies across 330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berryman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in TX
$162,583 industry payments
Medicare Practice Summary
Medicare Utilization ↗104,583
Medicare services
Top 10% in TX for medical oncology
2,896
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,504 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
31,800 | $33 | $234 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
27,102 | $0 | $2 |
| Daratumumab injection, 10 mg An injection of daratumumab, a monoclonal antibody medication, administered in a 10 mg dose. |
23,240 | $46 | $167 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,878 | $0 | $1 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,812 | $10 | $64 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
1,801 | $17 | $60 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
1,772 | $6 | $31 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
1,752 | $7 | $29 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,477 | $8 | $36 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,132 | $8 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
992 | $94 | $368 |
| Injection, granisetron hydrochloride, 100 mcg | 800 | $0 | $24 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
619 | $12 | $108 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
619 | $93 | $357 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
523 | $16 | $100 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
502 | $19 | $180 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
449 | $22 | $157 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
409 | $1 | $7 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
393 | $101 | $707 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
378 | $50 | $313 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
348 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
346 | $6 | $34 |
| Immunoglobulin subclass measurement A blood test that measures the levels of specific immunoglobulin subclasses to evaluate immune system function. |
340 | $8 | $236 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
277 | $11 | $96 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
208 | $3 | $14 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
181 | $58 | $211 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
111 | $2 | $19 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 109 | $89 | $657 |
| Tacrolimus level test A blood test to measure the amount of tacrolimus in your system. This helps ensure the medication is at a safe and effective level. |
105 | $13 | $101 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
99 | $9 | $56 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
92 | $7 | $431 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
79 | $1,180 | $4,929 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
77 | $10 | $75 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
76 | $69 | $70 |
| Additional vaccine administration This code covers the administration of each additional vaccine given during the same encounter. It is billed alongside the primary vaccine administration code. |
60 | $12 | $58 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
57 | $14 | $94 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
56 | $21 | $161 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
42 | $13 | $60 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
37 | $1 | $19 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
32 | $26 | $256 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
30 | $1,142 | $4,802 |
| PSA test (prostate cancer screening) | 28 | $18 | $94 |
| Pneumococcal vaccine, 13-valent | 27 | $253 | $570 |
| Hepatitis B vaccine, adult dosage An injection of the hepatitis B vaccine administered to adults as part of a three-dose immunization schedule. |
27 | $69 | $165 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
27 | $16 | $53 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
25 | $16 | $58 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $130 | $694 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
23 | $31 | $58 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
23 | $31 | $58 |
| Hepatitis B vaccine administration This procedure involves the injection of the hepatitis B vaccine to provide immunization against the hepatitis B virus. |
23 | $31 | $58 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
20 | $60 | $298 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
20 | $30 | $247 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $129 | $496 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
18 | $140 | $523 |
| Iron level test | 18 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
17 | $8 | $35 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
16 | $76 | $171 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
15 | $90 | $368 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.3% high complexity
54.5% medium
13.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$162,583
Total received (2018-2024)
Avg $23,226/year across 7 years
Top 9% in TX for medical oncology
49
Companies
330
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$149,861 (92.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,262 (4.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,460 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$17,637
2023
$5,964
2022
$35,442
2021
$28,140
2020
$11,635
2019
$32,145
2018
$31,622
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Karyopharm Therapeutics Inc.
$47,949
Takeda Pharmaceuticals U.S.A., Inc.
$40,647
GlaxoSmithKline, LLC.
$25,642
Amgen Inc.
$17,251
Celgene Corporation
$10,270
GENZYME CORPORATION
$5,325
E.R. Squibb & Sons, L.L.C.
$3,368
Genmab U.S., Inc.
$3,165
ABBVIE INC.
$2,668
Janssen Biotech, Inc.
$1,503
Astellas Pharma US Inc
$652
Incyte Corporation
$326
JAZZ PHARMACEUTICALS INC.
$315
ADC Therapeutics America, Inc.
$299
SANOFI-AVENTIS U.S. LLC
$267
Alexion Pharmaceuticals, Inc.
$247
Seagen Inc.
$209
PFIZER INC.
$200
Adaptive Biotechnologies Corporation
$188
Legend Biotech USA Inc.
$183
Pharmacyclics LLC, An AbbVie Company
$166
Rigel Pharmaceuticals, Inc.
$159
Merck Sharp & Dohme LLC
$158
AstraZeneca Pharmaceuticals LP
$156
Seattle Genetics, Inc.
$147
Janssen Scientific Affairs, LLC
$126
Daiichi Sankyo Inc.
$109
AbbVie Inc.
$100
Novartis Pharmaceuticals Corporation
$97
Jazz Pharmaceuticals Inc.
$80
SOBI, INC
$80
RECORDATI_RARE_DISEASES_INC.
$62
Genentech USA, Inc.
$61
MorphoSys, US Inc.
$47
CTI BioPharma Corp.
$41
Kyowa Kirin, Inc.
$39
Menarini Silicon Biosystems, Inc.
$38
Kite Pharma, Inc.
$33
Sobi, Inc
$28
Epizyme, Inc.,
$24
MENARINI SILICON BIOSYSTEMS, INC.
$22
INSYS Therapeutics Inc
$20
Lilly USA, LLC
$18
Agios Pharmaceuticals, Inc.
$18
Acrotech Biopharma Inc.
$18
EUSA Pharma (US) LLC
$17
Blueprint Medicines Corporation
$16
Merck Sharp & Dohme Corporation
$13
Verastem, Inc.
$11
Top 3 companies account for 70.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · BELEODAQ · BLENREP · BOSULIF · Blincyto · CABLIVI · CALQUENCE · CARVYKTI · CRESEMBA · Cellsearch · Columvi · Copiktra · Cresemba · DARZALEX · DEFITELIO · DIFICID · DOPTELET · Doptelet · ELITEK · EMPLICITI · ENJAYMO · EPKINLY · Epkinly · Fabhalta · ICLUSIG · IMBRUVICA · Imbruvica · JAKAFI · JAYPIRCA · Kyprolis · LIVTENCITY · Lunsumio · MONJUVI · NINLARO · OJJAARA · PREVYMIS · PROMACTA · Polivy · Pomalyst · Poteligeo · REBLOZYL · REZUROCK · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SYLVANT · SYNDROS · Sylvant · TAZVERIK · TECVAYLI · Tavalisse · ULTOMIRIS · VELCADE · VENCLEXTA · VONJO · VYXEOS · Vanflyta · Vonjo · XOSPATA · XPOVIO · Xospata · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for medical oncology in TX.
Equivalent to $155 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
90
Per 100K population
3.5
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Berryman is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), with speaking/promotional industry engagement in the top 9% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Berryman experienced with immune globulin infusion (octagam)?
Based on Medicare claims data, Dr. Berryman performed 31,800 immune globulin infusion (octagam) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berryman receive payments from pharmaceutical companies?
Yes. Dr. Berryman received a total of $162,583 from 49 companies across 330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berryman's costs compare to other medical oncologists in Dallas?
Dr. Berryman's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berryman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Dallas
Browse medical oncologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology